litlas
ログインアカウント作成

Thomas A. Davis

1986–2024 年に発表

67
論文数
19,037
被引用数
56
h 指数
67
i10 指数

被引用数

Thomas A. Davis の年別被引用数1986 年: 被引用 1 件1987 年: 被引用 14 件1988 年: 被引用 7 件1989 年: 被引用 7 件1991 年: 被引用 3 件1992 年: 被引用 2 件1994 年: 被引用 3 件1996 年: 被引用 3 件1997 年: 被引用 10 件1998 年: 被引用 39 件1999 年: 被引用 67 件2000 年: 被引用 68 件2001 年: 被引用 96 件2002 年: 被引用 97 件2003 年: 被引用 106 件2004 年: 被引用 140 件2005 年: 被引用 185 件2006 年: 被引用 164 件2007 年: 被引用 195 件2008 年: 被引用 205 件2009 年: 被引用 146 件2010 年: 被引用 140 件2011 年: 被引用 139 件2012 年: 被引用 125 件2013 年: 被引用 106 件2014 年: 被引用 112 件2015 年: 被引用 155 件2016 年: 被引用 139 件2017 年: 被引用 179 件2018 年: 被引用 133 件2019 年: 被引用 398 件2020 年: 被引用 461 件2021 年: 被引用 424 件2022 年: 被引用 414 件2023 年: 被引用 266 件2024 年: 被引用 374 件2025 年: 被引用 149 件2026 年: 被引用 3 件1990 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,108 件、この内訳の 34.5%中国: 引用元論文 580 件、この内訳の 9.5%ドイツ: 引用元論文 328 件、この内訳の 5.4%イギリス: 引用元論文 308 件、この内訳の 5%フランス: 引用元論文 249 件、この内訳の 4.1%イタリア: 引用元論文 226 件、この内訳の 3.7%カナダ: 引用元論文 176 件、この内訳の 2.9%日本: 引用元論文 167 件、この内訳の 2.7%オランダ: 引用元論文 166 件、この内訳の 2.7%スイス: 引用元論文 161 件、この内訳の 2.6%オーストラリア: 引用元論文 156 件、この内訳の 2.6%インド: 引用元論文 144 件、この内訳の 2.4%
0%34.5%その他 21.9%

機関

分野

  • Medicine57%
  • Immunology and Microbiology21.4%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Environmental Science4%
  • Engineering2%
  • Agricultural and Biological Sciences1.8%
  • その他4.9%

トピック

  • Immunotherapy and Immune Responses8.7%
  • Cancer Immunotherapy and Biomarkers7.1%
  • CAR-T cell therapy research5.2%
  • Immune Cell Function and Interaction4.8%
  • Glioma Diagnosis and Treatment4.1%
  • T-cell and B-cell Immunology3.8%
  • その他66.3%

共著者

全論文

検索で開く
  1. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

    著者: Michael Weller, Nicholas Butowski, David Tran, Lawrence D. Recht, Michael Lim, Hal W. Hirte, Lynn S. Ashby, Laszlo Mechtler, Samuel Goldlust, Fábio M. Iwamoto, Jan Drappatz, Donald M. O’Rourke, Mark Wong, Mark G. Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D. Turner, Michael Yellin, Tibor Keler, Thomas A. Davis, Roger Stupp, John H. Sampson, Nicholas Butowski, Jian Campian, Lawrence D. Recht, Michael Lim, Lynn S. Ashby, Jan Drappatz, Hal W. Hirte, Fábio M. Iwamoto, Laszlo Mechtler, Samuel Goldlust, Kevin Becker, Gene H. Barnett, Garth Nicholas, Annick Desjardins, Tara Benkers, Naveed Wagle, Morris D. Groves, Santosh Kesari, Zsolt Horváth, Ryan Merrell, Richard Curry, James O’Rourke, David M. Schuster, Mark Wong, Maciej M. Mrugała, Randy Jensen, John Trusheim, Glenn J. Lesser, Karl Bélanger, Andrew E. Sloan, Benjamin Purow, Karen Fink, Jeffrey J. Raizer, Michael Schulder, Suresh Nair, Scott Peak, James Perry, Alba A. Brandes, Michael Weller, Nimish Mohile, Joseph Landolfi, Jon Olson, Gaetano Finocchiaro, Ross Jennens, Paul DeSouza, Bridget A. Robinson, Marka R. Crittenden, Kent C. Shih, Alexandra Flowers, Shirley Ong, Jennifer Connelly, Costas G. Hadjipanayis, Pierre Giglio, Frank E. Mott, David Mathieu, N. Lessard, Sanchez Juan Sepulveda, József Lövey, Helen Wheeler, Po-Ling Inglis, Claire Hardie, Daniela A. Bota, Maciej S. Lesniak, Jana Portnow, Bruce Frankel, Larry Junck, Reid C. Thompson, Lawrence Berk, John Paul McGhie, David Macdonald, Frank Saran, Riccardo Soffietti, Deborah T. Blumenthal, Sá Barreto Costa Marcos André de, Anna K. Nowak ほか 93 名 - The Lancet Oncology 2017 被引用: 1,113

  2. Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

    著者: David A. Reardon, Annick Desjardins, James J. Vredenburgh, Donald M. O’Rourke, David Tran, Karen Fink, Burt Nabors, Gordon Li, Daniela A. Bota, Rimas V. Lukas, Lynn S. Ashby, J. Paul Duic, Maciej M. Mrugała, Scott Cruickshank, Laura Vitale, Yi He, Jennifer A. Green, Michael Yellin, Christopher D. Turner, Tibor Keler, Thomas A. Davis, John H. Sampson - Clinical Cancer Research 2020 被引用: 177

  3. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

    著者: James M. Schuster, R. K. Lai, Lawrence D. Recht, David A. Reardon, Nina A. Paleologos, Morris D. Groves, Maciej M. Mrugała, Randy L. Jensen, Joachim M. Baehring, Andrew E. Sloan, Gerald E. Archer, D. D. Bigner, Scott Cruickshank, J. A. Green, Tibor Keler, Thomas A. Davis, Amy B. Heimberger, John H. Sampson - Neuro-Oncology 2015 被引用: 417

  4. Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification

    著者: Shailesh Agarwal, Shawn Loder, Cameron Brownley, David Cholok, Laura Mangiavini, John Li, Christopher Breuler, Hsiao Hsin Sung, Shuli Li, Kavitha Ranganathan, Joshua M. Peterson, Ronald G. Tompkins, David N. Herndon, Wenzhong Xiao, Dolrudee Jumlongras, Bjørn R. Olsen, Thomas A. Davis, Yuji Mishina, Ernestina Schipani, Benjamin Lévi - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 被引用: 223

  5. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

    著者: F. Stephen Hodi, Martín C. Mihm, Robert J. Soiffer, Frank G. Haluska, Marcus O. Butler, Michael V. Seiden, Thomas A. Davis, Rochele Henry-Spires, Suzanne MacRae, Ann Willman, Robert F. Padera, Michael T. Jaklitsch, Sridhar Shankar, Teresa C. Chen, Alan J. Korman, James P. Allison, Glenn Dranoff - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 997

  6. Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

    著者: Madhav V. Dhodapkar, Mario Sznol, Biwei Zhao, Ding Wang, Richard D. Carvajal, Mary Louise Keohan, Ellen Chuang, Rachel E. Sanborn, Jose Lutzky, John D. Powderly, Harriet M. Kluger, Sheela Tejwani, Jennifer Green, Venky Ramakrishna, Andrea Crocker, Laura Vitale, Michael Yellin, Thomas A. Davis, Tibor Keler - Science Translational Medicine 2014 被引用: 357

  7. Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets

    著者: Nina Bhardwaj, Philip Friedlander, Anna C. Pavlick, Marc S. Ernstoff, Brian Gastman, Brent A. Hanks, Brendan D. Curti, Mark R. Albertini, Jason J. Luke, Ana-Belén Blázquez, Sreekumar Balan, Davide Bedognetti, Joseph Beechem, Andrea Crocker, Leonard D’Amico, Patrick Danaher, Thomas A. Davis, Thomas Hawthorne, Bruce W. Hess, Tibor Keler, Lisa Lundgren, Chihiro Morishima, Nirasha Ramchurren, Darawan Rinchai, Andres Μ. Salazar, Bob Salim, Elad Sharon, Laura Vitale, Ena Wang, Sarah Warren, Michael Yellin, Mary L. Disis, Martin A. Cheever, Steven P. Fling - Nature Cancer 2020 被引用: 126

  8. IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

    著者: David G. Maloney, Antonio J Grillo-López, Christine A. White, David Bodkin, Russell J. Schilder, James A. Neidhart, Nalini Janakiraman, Kenneth A. Foon, Tina-Marie Liles, B.K. Dallaire, Ken Wey, Ivor Royston, Thomas A. Davis, Ronald Levy - Blood 1997 被引用: 1,697

  9. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

    著者: Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, Linda J. Freezer, Kathleen E. Morton, Sharon Mavroukakis, Paul H. Duray, Seth M. Steinberg, James P. Allison, Thomas A. Davis, Steven A. Rosenberg - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 1,573

  10. Orthopaedic osseointegration: Implantology and future directions

    著者: Archie L. Overmann, Conrado Aparicio, John T. Richards, Isha Mutreja, Nicholas G. Fischer, Sean M. Wade, Benjamin K. Potter, Thomas A. Davis, Joan E. Bechtold, Jonathan A. Forsberg, Devaveena Dey - Journal of Orthopaedic Research® 2019 被引用: 131

  11. A review of the biochemistry of heavy metal biosorption by brown algae

    著者: Thomas A. Davis, Bohumil Volesky, Alfonso Mucci - Water Research 2003 被引用: 2,375

  12. Heterotopic Ossification: Basic-Science Principles and Clinical Correlates

    著者: Kavitha Ranganathan, Shawn Loder, Shailesh Agarwal, Victor W. Wong, Jonathan A. Forsberg, Thomas A. Davis, Stewart C. Wang, Aaron W. James, Benjamin Lévi - Journal of Bone and Joint Surgery 2015 被引用: 387

  13. The traumatic bone: trauma-induced heterotopic ossification

    著者: Devaveena Dey, B. M. Wheatley, David Cholok, Shailesh Agarwal, Paul B. Yu, Benjamin Lévi, Thomas A. Davis - Translational research 2017 被引用: 144

  14. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

    著者: Denise A. Yardley, Robert Weaver, Michelle Melisko, Mansoor N. Saleh, Francis P. Arena, Andres Forero, Tessa Cigler, Alison Stopeck, Dennis L. Citrin, Ira A. Oliff, Rebecca Bechhold, Randa Loutfi, Agustin A. García, Scott Cruickshank, Elizabeth Crowley, Jennifer Green, Thomas Hawthorne, Michael Yellin, Thomas A. Davis, Linda T. Vahdat - Journal of Clinical Oncology 2015 被引用: 189

  15. Topical advances in wound care

    著者: Alexander Stojadinovic, Jay W. Carlson, Gregory S. Schultz, Thomas A. Davis, Eric A. Elster - Gynecologic Oncology 2008 被引用: 145

  16. Scleraxis-Lineage Cells Contribute to Ectopic Bone Formation in Muscle and Tendon

    著者: Shailesh Agarwal, Shawn Loder, David Cholok, Joshua M. Peterson, John Li, Christopher Breuler, R. Cameron Brownley, Hsiao Hsin Sung, Michael T. Chung, Nobuhiro Kamiya, Shuli Li, Bin Zhao, Vesa Kaartinen, Thomas A. Davis, Ammar T. Qureshi, Ernestina Schipani, Yuji Mishina, Benjamin Lévi - Stem Cells 2016 被引用: 113

  17. An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth

    著者: Hubert Lam, Lisa K. McNeil, Hanna Starobinets, Victoria L. DeVault, Roger B. Cohen, Przemyslaw Twardowski, Melissa L. Johnson, Maura L. Gillison, Mark N. Stein, Ulka N. Vaishampayan, Arthur P. DeCillis, James J. Foti, Vijetha Vemulapalli, Emily Tjon, Kyle Ferber, Daniel B. DeOliveira, Wendy Broom, Parul Agnihotri, Elizabeth M. Jaffee, Kwok‐Kin Wong, Charles G. Drake, Pamela M. Carroll, Thomas A. Davis, Jessica B. Flechtner - Cancer Discovery 2021 被引用: 57

  18. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy

    著者: Michael Weller, Kerstin Kaulich, Bettina Hentschel, Joerg Felsberg, Dorothee Gramatzki, Torsten Pietsch, Matthias Simon, Manfred Westphal, Gabriele Schackert, J. C. Tonn, Andreas von Deimling, Thomas A. Davis, William A. Weiss, Markus Loeffler, Guido Reifenberger, for the German Glioma Network - International Journal of Cancer 2013 被引用: 118

  19. Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

    著者: Patrick A. Ott, Omid Hamid, Anna C. Pavlick, Harriet M. Kluger, Kevin B. Kim, Peter D. Boasberg, Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, Thomas A. Davis, Mario Sznol, Patrick Hwu - Journal of Clinical Oncology 2014 被引用: 98

  20. Alarming Cargo: The Role of Exosomes in Trauma-Induced Inflammation

    著者: Sarah A. Walsh, Benjamin W. Hoyt, Cassie J. Rowe, Devaveena Dey, Thomas A. Davis - Biomolecules 2021 被引用: 39

  21. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

    著者: Allan D. Kirk, David M. Harlan, Nicholas Armstrong, Thomas A. Davis, Yinchen Dong, Gary S. Gray, Xuening Hong, David W. Thomas, John H. Fechner, Stuart J. Knechtle - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 被引用: 933

  22. Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

    著者: Howard A. Burris, Jeffrey R. Infante, Stephen M. Ansell, John Nemunaitis, Geoffrey R. Weiss, Víctor M. Villalobos, Branimir I. Šikić, Matthew H. Taylor, Donald W. Northfelt, William E. Carson, Thomas Hawthorne, Thomas A. Davis, Michael Yellin, Tibor Keler, Timothy N. J. Bullock - Journal of Clinical Oncology 2017 被引用: 132

  23. Effect of spaceflight on human stem cell hematopoiesis: suppression of erythropoiesis and myelopoiesis

    著者: Thomas A. Davis, William P. Wiesmann, William R. Kidwell, Tom Cannon, Laura Kerns, Catherine Serke, Ted Delaplaine, Alex Pranger, Kelvin P. Lee - Journal of Leukocyte Biology 1996 被引用: 95

  24. The role of neutrophil extracellular traps and TLR signaling in skeletal muscle ischemia reperfusion injury

    著者: Nicole Edwards, Charles Hwang, Simone Marini, Chase A. Pagani, Philip Spreadborough, Cassie J. Rowe, Pauline Yu, Annie Mei, Noelle D. Visser, Shuli Li, Geoffrey E. Hespe, Amanda K. Huber, Amy L. Strong, Miriam A. Shelef, Jason S. Knight, Thomas A. Davis, Benjamin Lévi - The FASEB Journal 2020 被引用: 38